Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences
Open Access
- 1 August 2001
- journal article
- review article
- Published by Wiley in Liver International
- Vol. 21 (4) , 225-232
- https://doi.org/10.1034/j.1600-0676.2001.021004225.x
Abstract
The pathogenesis of autoimmune liver disease and autoimmunity associated with chronic viral hepatitis remains poorly understood. One of the major hurdles to a deeper understanding of these pathological processes is the absence of clearly defined inductive mechanisms, which, if identified and characterised, could guide clinical strategies for their prevention or allow therapeutic intervention. Molecular mimicry leading to crossreactive autoimmune responses has gained strong experimental support in the past decade. A fundamental premise of this hypothesis is the involvement of a mimicking environmental trigger. In view of the numerous viral and bacterial agents epidemiologically linked to autoimmune liver diseases, we and others have proposed molecular mimicry to be an important mechanism in these diseases. We also propose similar crossreactive mechanisms to operate in the generation of autoimmunity in viral hepatitis. This review focuses on molecular mimicry at the level of the B‐cell, as few data on T‐cell crossreactivity in liver disease are thus far available.Keywords
This publication has 50 references indexed in Scilit:
- Thyroid peroxidase is a molecular mimicry target of anti-hepatitis C virus humoral responseJournal of Hepatology, 2000
- Double reactivity to Ecoli/pyruvate dehydrogenase complex-E2characterises primary biliary cirrhosisJournal of Hepatology, 2000
- Antibodies against the COOH-terminal region of E. coli ClpP protease in patients with primary biliary cirrhosisJournal of Hepatology, 2000
- Generation of liver/kidney microsomal-1 antibody in HCV infection: The role of molecular mimicryJournal of Hepatology, 2000
- Autoimmune Regulator Is Expressed in the Cells Regulating Immune Tolerance in Thymus MedullaBiochemical and Biophysical Research Communications, 1999
- Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis CJournal of Hepatology, 1994
- Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti‐liver‐kidney microsome type‐1 antibodies (LKM1)European Journal of Immunology, 1993
- M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with primary biliary cirrhosis and in patients with recurrent bacteriuriaJournal of Hepatology, 1993
- Clinical Variation of Autoimmune Polyendocrinopathy–Candidiasis–Ectodermal Dystrophy (APECED) in a Series of 68 PatientsNew England Journal of Medicine, 1990
- Anti-liver kidney microsome antibody recognizes a cytochrome P450 from the IID subfamily.The Journal of Experimental Medicine, 1988